The Par polarity proteins play key roles in asymmetric division of Drosophila melanogaster stem cells; however, whether the same mechanisms control stem cells in mammals is controversial. Although necessary for mammary gland morphogenesis, Par3 is not essential for mammary stem cell function. We discovered that, instead, a previously uncharacterized protein, Par3-like (Par3L), is vital for mammary gland stem cell maintenance. Par3L function has been mysterious because, unlike Par3, it does not interact with atypical protein kinase C or the Par6 polarity protein. We found that Par3L is expressed by multipotent stem cells in the terminal end buds of murine mammary glands. Ablation of Par3L resulted in rapid and profound stem cell loss. Unexpectedly, Par3L, but not Par3, binds to the tumour suppressor protein Lkb1 and inhibits its kinase activity. This interaction is key for the function of Par3L in mammary stem cell maintenance. Our data reveal insights into a link between cell polarity proteins and stem cell survival, and uncover a biological function for Par3L.
The Par3 protein sits at the apex of a signalling network that controls apical/basal polarity and spindle orientation, not only in differentiated epithelial cells but also in the Drosophila neuroblast, intestinal and sensory organ precursor stem cells 1, 2 . Loss of spatially organized Par signalling through atypical protein kinase C (aPKC) in these stem cells disrupts asymmetric cell division and perturbs self-renewal and the differentiation of daughter cells. Although the Par proteins are conserved throughout the metazoa, it remains unclear whether their functions have been retained in mammalian stem cells. For example, although the Par3 pathway does seem to play a role in the asymmetric divisions of radial glial progenitors 3 , it is not essential for mammary gland regeneration from stem cells 4 , and aPKC is completely dispensable for primitive and adult haematopoietic stem cell polarization, activity and blood formation 5 .
Whereas in lower animals the Par proteins and aPKC are each encoded only by single genes, diversification has occurred in the vertebrate lineage, and the various isoforms can have distinct biological functions. For instance, isoforms of Par6 are not interchangeable in zebrafish 6 . In 2002 we cloned a gene (pard3b) closely related to the Par3 gene (pard3), which expresses a protein we named Par3-like (Par3L; ref. 7) . The function of Par3L has been enigmatic because, unlike Par3, it does not bind to either Par6 or aPKC, but exogenous Par3L can co-localize with these proteins and with Par3 at epithelial tight junctions 7, 8 . Nothing has been known about any biological roles for Par3L. It has not been shown to participate in cell polarization or in stem cell functions. Here we identify Par3L as an essential factor for mouse mammary stem cell maintenance, and show that it acts by suppressing the kinase activity of the Par4 or Lkb1 (also known as Stk11) polarity protein.
RESULTS

Par3L is expressed in cap cells and is required for mammary ductal outgrowth
To test for a function of Par3L in mammary gland development, we first developed Par3L-specific antibodies ( Supplementary Fig. 1a ,b) and stained sections from mature and developing murine mammary glands. In mature glands Par3L staining was restricted to the tight junctions of luminal epithelial cells ( Fig. 1a ), as predicted from previous studies 8, 9 . Strikingly, however, in the developing glands Par3L was detected at the cell cortex in the cap cells of terminal end buds ( Fig. 1b ). Cap cells express s-SHIP and, using a transgenic mouse model (Tg11.5kb-GFP) that expresses green fluorescent protein (GFP) from the s-SHIP promoter 9 , they have been shown to be active, multipotent stem cells that can regenerate a functional mammary gland after transplantation into cleared fat pads of recipient mice 10 . We refer to these cells as mammary repopulating units (MRUs). They are negative for cytokeratin 14 (CK14; known as Krt14 in mouse) and cytokeratin 8 (CK8; known as Krt8 in mouse), but are CD49f and CD24 positive 10 . Notably, cap cells that express GFP from the s-SHIP promoter were also strongly positive for Par3L, whereas the majority of the terminal end bud body cells, which lack GFP expression, were negative for Par3L ( Supplementary Fig. 1c ).
To test the function of Par3L in these mammary gland cells, two lentiviral short hairpin RNAs (shRNAs) were developed to target the murine Par3L, with ∼70% knockdown by Par3L shRNA 1 and 99% knockdown by Par3L shRNA 2 when compared with the luciferase shRNA (Luc shRNA) control ( Supplementary Fig. 1d,e ). Par3L was silenced by these two shRNAs in mammary gland stem/progenitor cells, which were subsequently transplanted into clear fat pads for mammary gland regeneration. Whole mount staining of these fat pads showed that Par3L shRNA 2 markedly reduced mammary gland take rate as compared to the controls (Fig. 1d, Par3L significantly reduced fat pad filling for those glands that did regenerate ( Fig. 1d ,f). Ductal branching was measured in the fat pads transplanted by mammary cells with Par3L shRNA 1, which was permissive for mammary gland outgrowth. The number of ductal branching points per unit area was significantly reduced ( Fig. 1d,g) . Importantly, these phenotypes were reversed by the expression of human Par3L, which is resistant to shRNA-mediated silencing, demonstrating that the defect is specific to Par3L knockdown rather than to off-target effects of the shRNAs. Because Par3L is expressed at either the cortex of cap cells in developing mammary glands or the tight junction of luminal epithelial cells in mature mammary glands, the phenotype caused by Par3L depletion could be due to defects in either type of cell. To further address this issue, we stained mammary gland sections to examine the structure of mammary glands. Silencing of Par3L substantially reduced anti-Par3L antibody staining of mammary glands ( Fig. 1c ). Moreover, the normal structure of terminal end buds was severely disrupted in glands that grew out from mammary stem cells transduced with Par3L shRNA 2. All the terminal end bud cells were CK8 positive and there was no distinct cap cell layer (Fig. 1c ). This experiment demonstrates that Par3L silencing causes defects in ductal outgrowth and terminal end bud structures, probably through effects on the cap cell MRUs.
Par3L is essential for mammary stem cell maintenance
To further investigate whether Par3L affects MRUs, we quantified the in vivo regeneration capacity of isolated mammary cells, after implantation into the cleared fat pads of syngeneic recipient mice, using limiting dilution assays 11, 12 . On the basis of positive outgrowths scored for each dilution, the MRU frequency was 1/2,100 for wildtype cells, in line with previous results 11, 12 , but only 1/215,000 for cells expressing Par3L shRNA 2 ( Table 1 ). These data indicate that silencing of Par3L causes a highly significant ∼100-fold decrease in functional MRUs. By contrast, no significant decrease in MRUs was observed on depletion of the closely related Par3 gene 4 .
As an in vitro assay for stem cell survival we used a serial colonyforming assay, a schematic representation of which is shown in Supplementary Fig. 2a . Single mammary cell suspensions were prepared from mammary cells transduced with lentivector shRNAs against Par3L or Luc shRNA control, and seeded into Matrigel. Colonies formed ( Fig. 2a ) after one week and were scored, then trypsinized and replated as single cells into fresh Matrigel. The number of CFCs increases in the second and third passages of the wild-type control (Fig. 2b) . Importantly, this serial passage procedure is strongly enriching for MRUs, as shown by the very high efficiency with which the control cells from tertiary colonies could repopulate fat pads in vivo (Supplementary Fig. 2b ). When Par3L was depleted, however, the number of CFCs was significantly lower, even in the primary culture, and dropped substantially in subsequent passages, for two independent shRNAs ( Fig. 2a,b ). These results are consistent with a rapid depletion of functional stem cells in the absence of Par3L expression. We reasoned that Par3L might be required cell autonomously for MRU survival, or might alternatively support the stem cell micro-environment in a cell non-autonomous fashion. To distinguish these two possibilities, we used a competition assay to compare the efficiencies of ductal outgrowth by Luc shRNA control MRUs versus Par3L-depleted cells. Cells expressing the Par3L shRNA 2 were marked green with GFP, and those expressing the Luc shRNA were marked red with mApple. Equal numbers of cells were then mixed and implanted into cleared fat pads, as represented in Supplementary Fig. 2c . If Par3L were necessary for niche maintenance, or for secretion of factors that support stem cells, then it would be predicted that green, Par3Ldepleted cells would be unable to form a niche and negatively impact the outgrowth of neighbouring control red cells. Conversely, the wildtype cells should provide a functional niche for green Par3L-depleted stem cells, enabling their outgrowth. Reproducibly, however, only the red control cells populated the entire fat pad, and the green Par3Ldepleted MRUs contributed negligibly to ductal outgrowth (Fig. 2c) . When, instead, an equal mix of red and green control cells was implanted into the fat pads, both populations were able to contribute efficiently to the regenerated ductal trees. We conclude from these data that Par3L is essential for murine mammary gland stem cell function, and that it functions cell autonomously.
Depletion of Par3L promotes apoptosis and differentiation into CK8 + cells Some MRUs in young mice are actively cycling 9 . Therefore, a decrease in relative MRU number could arise from either reduced proliferation or increased cell death. To distinguish these possibilities we stained the colonies grown in Matrigel for Ki67 (also known as Mki67) or cleaved Caspase-3, and for CK8 as a luminal epithelial marker and CK14 as a myoepithelial marker. Proliferation, as marked by Ki67 + Figure 5 Par3L maintains mammary stem cells through interaction with Lkb1. (a) Par3L interacts with Lkb1 but not aPKC, whereas Par3 interacts with aPKC but not Lkb1. About 2% of Lkb1 was captured by Par3L, whereas only ∼0.02% Lkb1 precipitated with Par3. (b) The endogenous interaction between Par3L and Lkb1 was confirmed by co-immunoprecipitation (co-IP) using mouse kidney lysates, which express relatively high levels of Par3L. WB, western blot. (c) The region on Par3L required for Lkb1 binding was mapped between PDZ2 and PDZ3 domains. Replacement of this region of Par3L with the corresponding region of Par3 disrupts the interaction between Lkb1 and Par3L. All full scan images are presented in Supplementary Fig. 6. (d,e ) Mammary gland regeneration assay. Wild-type human Par3L can rescue mammary gland regeneration from Par3L-depleted mammary cells, whereas the Lkb1-binding-deficient Par3L mutant is unable to do so. (f) Representative images of the staining of tertiary colonies for CK8, CK14 and cleaved Caspase-3. (g,h) Quantification of CK14 + CK8 + dual-positive (g) and cleaved Caspase-3 + (h) cells in in vitro serial colony-forming assay. Wild-type human Par3L, but not the mutant Par3L, was able to reverse the Par3L depletion effects. The graph shows the mean ± s.e.m. n represents the number of colonies that were scored. Statistical significance was calculated for each experimental group, compared to the Luc shRNA control group. P values were calculated with a Student t-test. cells, was not affected by expression of Par3L shRNAs (Fig. 3a,b) , but cleaved Caspase-3 staining was significantly increased with Par3L shRNA 2, and this was reduced to control levels by hPar3L expression (Fig. 3a,c) . Moreover, the number of basal-like (CK14 + ) and dualpositive (CK8 + /CK14 + ) cells, which are possible progenitors, was substantially reduced by both Par3L shRNAs, an effect that was efficiently reversed by hPar3L expression (Fig. 3a,d) . In contrast, we could detect no difference in either Ki67 or Caspase-3 staining for mature ducts arising from cells expressing Par3L shRNA 1 as compared to Luc shRNA controls, and there were no detectable CK8 + /CK14 + cells (Fig. 3e,f) . These data suggest that loss of Par3L specifically depletes MRUs by promoting apoptosis and/or preventing their self-renewal, but has no effect on the survival of differentiated mammary cells.
Par3L expression is not entirely specific to cap cells, because it was also detectable at the tight junctions of luminal cells in mature ducts (Fig. 1a) . Therefore, to test more definitively for a stem-cellspecific function of Par3L, we used fluorescence-activated cell sorting (FACS) to purify GFP + MRUs to homogeneity from the Tg11.5kb-GFP mice ( Supplementary Fig. 4a,b) . The GFP + cells were transduced with lentivectors expressing mApple plus Luc shRNA (control) or Par3L shRNA 2. The cells were then grown into colonies in Matrigel, and passaged as described above ( Supplementary Fig. 2 ). Most of the control colonies continued to express GFP, and were positive for the lentiviral marker (Fig. 4a,d) . However, very few cells transduced with Par3L shRNA 2 formed colonies (Fig. 4a,d) . Moreover, those colonies that grew out were generally smaller, and less positive for mApple ( Fig. 4a,b ), suggesting that there was selection against cells containing multiple copies of the shRNA-mApple vector. The effect of Par3L depletion is even more striking when GFP + colonies are scored. After the third passage more than 50% of the colonies in the Luc shRNA control group were GFP + , whereas only 17% of surviving colonies in the Par3L shRNA 2 group were GFP + (Fig. 4e ). This result demonstrates that Par3L depletion causes rapid loss of GFP + mammary stem cells. We next focused on the GFP + mApple + colonies to understand what effects Par3L depletion might have on these GFP + MRUs. In surviving colonies from cells transduced with Par3L shRNA 2, over 60% of cells were CK8 + , which is not different from the Luc shRNA control. However, only 16% of cells were CK14 + in the Par3L shRNA 2 group, a significant decrease when compared with 79% CK14 + cells for the Luc shRNA control (Fig. 4b,f ). This result is consistent with our earlier observation that Par3L depletion causes loss of basal CK14 + or CK8 + CK14 + dual-positive cells (Fig. 3a,d) . Moreover, the surviving Par3L-depleted colonies had a substantially higher apoptotic index (Fig. 4c,f) . We conclude that Par3L possesses an MRU-specific function that is essential for stem cell maintenance.
Par3L, but not Par3, associates with Lkb1
How might Par3L act to maintain MRU survival? The Par3L protein does not bind to aPKC or Par6, so we tested other polarity proteins, and identified an unanticipated interaction with Lkb1, the mammalian homologue of the Caenorhabditis elegans PAR4 polarity protein (Fig. 5a ). The endogenous association of the two proteins was confirmed using lysates from mouse kidneys, which express Par3L at relatively high levels (Fig. 5b) . This interaction is specific, because Lkb1 does not bind the Par3 protein (which was able to bind aPKC, Fig. 5a ). We next identified the region of Par3L required for Lkb1 binding. As shown in Supplementary Fig. 5 and Fig. 5c , the interaction involves the PDZ2-PDZ3 region of Par3L, and specifically requires a small region lying between the two PDZ domains, of no known function, and which shows no sequence similarity to the same region in Par3 (or to any other sequence in the GenBank database). Replacement of the Par3L sequence in this region with that from Par3 abolished Lkb1 binding by full-length hPar3L (Fig. 5c ). Therefore, this short Par3L sequence is required for Lkb1 binding. To determine if the interaction has biological relevance, we asked if the mutant could rescue mammary outgrowth in the fat pad repopulation assay. Importantly, although the wild-type hPar3L efficiently rescued ductal outgrowth, the Lkb1-binding-defective mutant did not ( Fig. 5d,e) . Moreover, only the wild-type hPar3L rescued colony formation in vitro by Par3L-depleted mammary cells, reducing cleaved Caspase-3 staining and increasing to control levels the number of CK 14 + /CK8 + dual-positive cells present in each colony. The mutant Par3L was unable to suppress apoptosis and only partially reversed the effects on CK14 + /CK8 + abundance (Fig. 5f-h) . Together, these data strongly suggest that Lkb1 binding to Par3L is crucial for the maintenance of murine mammary stem cells.
Par3L suppresses Lkb1 kinase activity
We next tested whether Par3L modulates Lkb1 activity. To do so, we created stably transduced HEK293T cells expressing either wildtype or mutant Par3L, and probed lysates for phosphorylated AMPK, a downstream target of Lkb1. Notably, the expression of wild-type Par3L in HEK293T cells inhibited AMPK phosphorylation, with no change in expression levels of either Lkb1 or AMPK, whereas the mutant had significantly less inhibitory effect on phospho-AMPK ( Fig. 6a,b ). We were unable to test this effect in mammary stem cells because we could not purify them in sufficient numbers for the biochemical experiments. Instead, we carried out a serial colonyforming assay to determine if an increase in Lkb1 activity in the stem cells would alter their behaviour. Strikingly, co-expression of Lkb1 and its activator, Stradα, strongly suppressed colony outgrowth in the serial colony-forming assay. The few colonies that grew in the presence of Lkb1 + Stradα had a significantly higher apoptotic index, as measured by staining for cleaved Caspase-3 (Fig. 6e,f) . We conclude that Par3L can inhibit Lkb1, and that uncontrolled Lkb1 activity severely compromises mammary stem cell survival.
DISCUSSION
Taken together, these data reveal a biological function for Par3L, a previously uncharacterized protein that is closely related to the Par3 polarity protein 7, 8 . Both proteins possess three PDZ domains and a conserved amino-terminus that in Par3 homodimerizes. Par3 also associates with other components of the polarity machinery, including Par6 and aPKC, and functions in many cellular contexts to create spatial asymmetries 2 . Pertinently, the Par polarity machinery is required for asymmetric cell divisions of many stem cells, including the C. elegans zygote, Drosophila neuroblasts and mammalian radial glial progenitors [1] [2] [3] . However, it is dispensable in other situations, including haematopoietic stem cell and mammary stem cell maintenance 4, 5 . Whether the Par3L isoform, which does not bind to Par6 or aPKC, plays any role either in cell polarity or in stem cell function has not been previously addressed. We now show that Par3L is expressed in one important subset of mammary stem cells, the cap cells of the terminal end buds 9 , and is essential for their maintenance. Moreover, Par3L but not Par3 binds to a distinct polarity protein called Par4 or Lkb1.
We propose that Par3L maintains mammary stem cells through suppression of Lkb1 kinase activity, and that loss of this restraint results in a failure of self-renewal and increased apoptosis. This model is in accord with known functions of Lkb1, which is capable of driving p53-dependent apoptosis when overexpressed 13, 14 , and which has been recently identified as an essential factor in a caspase-independent cell death and extrusion pathway in C. elegans 15 . Lkb1 is also required for the maintenance of haematopoietic stem cell dormancy [16] [17] [18] . Consistent with our model, the conditional deletion of Lkb1 in mammary glands promotes ductal hyperbranching, which is the opposite of the phenotype caused by loss of Par3L, and promotes tumorigenesis 19 . It will be of interest to determine if Par3L functions to restrain Lkb1 activity in other mammalian stem cell populations and perhaps acts as a tumour promoter through suppression of Lkb1 activity. Lkb1 is a master kinase that regulates 14 downstream protein kinases, and an important question for the future concerns which of these kinases mediates the effects of Lkb1 on mammary stem cell maintenance. We note that SIK1 couples LKB1 to p53-dependent apoptosis triggered by cell detachment 13 . Finally, we speculate that in Drosophila-which does not contain a Par3L gene-the negative regulation of LKB1 is occupied by Bazooka, the fly homologue of Par3. transgenic (Tg11.5kb-GFP) mice were provided by Larry Rohrschneider 9 . To isolate mammary gland cells, the third to fifth pairs of mammary glands were removed from eight-week-old C3H female mice, minced with scissors and digested in digestion medium (DMEM/F12, 2 mg ml −1 collagenase I (Roche), 5 mg ml −1 insulin (Sigma), 200 U ml −1 Nystatin (Sigma), 100 U ml −1 penicillin/streptomycin) for 45 min at 37 • C. Epithelial organoids were collected by centrifugation at 1,000 rpm for 5 min. The cell pellet was washed in 5 ml of DMEM/F12 containing DNase I and centrifuged at 1,000 rpm for 5 min. The pellet was resuspended in 5 ml DMEM/F12 10% fetal bovine serum followed by 15 s of centrifugation at 1,500 rpm five times. The cells were resuspended in 1 ml of fresh trypsin/EDTA (Invitrogen) and incubated at 37 • C for 12 min, dissociated into a single-cell suspension and passed through a cell strainer (BD) to obtain a single-cell suspension of mammary gland cells. Freshly isolated mammary gland cells were transduced by lentivirus in a final volume of 200 µl for 1 h. After transduction, cells were seeded into six-well low attachment dishes (Corning) and grown as mammosphere cultures for 2-5 days before transplantation. Transplantation of the mammary cells into the cleared fat pads of three-week-old recipients were as described in ref. 20. Briefly, incisions were made around each nipple of the fourth pair and parts of the fat pads were pulled through the openings. The endogenous mammary gland was removed. Cells were suspended in DMEM/F12 supplemented with 2% B27 and 10% growth-factorreduced Matrigel and injected into the cleared fat pad. Skin was closed by tissue adhesive. The number of mice used in each experiment was predetermined by power analysis. Transplanted mice were killed after 6-8 weeks to examine the mammary gland outgrowth. Experiments were not randomized or blinded to allocation during experiments or outcome assessment. All experiments were carried out in accordance with AAALAC guidelines and with Vanderbilt University Institutional Animal Care and Use Committee approval.
Plasmids. pLVTHM, psPAX2 and pMD2.G were provided by Didier Trono 21 .
pLVTHM was modified to change the enhanced green fluorescent protein tag to mApple and a BamHI-NotI-EcoRI linker was incorporated after the tag. ShRNAs were cloned into the ClaI-MluI sites of pLVTHM or pLVTHM-mApple. The sequences are the following: Luc shRNA, 5 -CGTACGCGGAATACTTCGA-3 ; Par3L shRNA 1, 5 -GGGAATAAGTCTCGAGAAA-3 ; Par3L shRNA 2, 5 -GGGAAACTCTTCTGGGAAA-3 . The mApple construct was provided by Merrifield and subcloned into pLVTHM (ref. 22). Par3L was amplified by PCR and subcloned in pLVTHM-Venus. Lkb1 and Stradα were PCR amplified, linked through the 2A peptide and subcloned into pLVTHM-Venus. Lentivirus was packaged in HEK293T cells in 15 cm dishes by calcium phosphate transfection. Lentiviral plasmid, packaging plasmid (psPAX2) and coat protein plasmid (pMD2.G) were used at a 1.5:1:1 ratio. Viral supernatants were collected after 2 days, 0.45 µm filtered and concentrated with 100 k ultrafilters (Millipore). Concentrated virus was stored at −80 • C, and titred using HEK293Tcells.
Antibodies. The primary antibodies were for CK14 (Covance, PRB-155P, 1:1,000), CK8 (Troma-1, 1:250), cleaved Caspase-3 (Cell Signaling, 9664, 1:100), Ki67 (Invitrogen, 18-0191Z, 1:75), LKB1 (Cell Signaling, 3050, 1:1,000), aPKC (Santa Cruz, sc-216, 1:1,000), Myc (9E10), AMPK (Cell Signaling, 2532, 1:1,000), Phospho-AMPK (Cell Signaling, 2535, 1:1,000), β-catenin (BD, 610153, 1:5,000). Draq5 (Cell Signaling, 4084, 1:200) was used to detect DNA. The Par3L antibody was created by Cocalico in guinea pigs. The antigen was a keyhole limpet haemocyaninconjugated peptide against the carboxy-terminal sequence of murine Par3L. The antibody was purified using peptide-coupled beads and used at 1:500 dilution in immunoblots and 1:150 dilution in immunostaining. A pressure cooker (Retriever 2100) was used for antigen retrieval. Alexa Fluorochrome-conjugated secondary antibodies were purchased from Invitrogen and used at 1:1,000 dilution for staining. Horseradish peroxidase-conjugated secondary antibodies were purchased from Jackson Immunolab and used at 1:10,000 dilution for western blots. Confocal microscopy images were taken on an LSM510 confocal microscope (Zeiss) at the VUMC Cell Imaging Shared Resource.
FACS.
Freshly isolated mammary gland cells from Tg11.1kbGFP mice were labelled for lineage markers PE-CD31 (MEC13.3, BD), PE-CD45 (30-F11, BD) and PE-Ter119 (TER-119, BD) for 30 min at 4 • C. 7AAD (1:200, BD) was added before sorting. Cells were sorted on a FACSDiva. GFP + PE − 7AAD − single cells were collected for the experiments.
In vitro assay. Mammary gland cells were cultured in suspension for 3 days after virus transduction to enable recovery. Cell clusters were dissociated into single cells by 0.05% trypsin-EDTA at 37 • C for 30-60 min. Cells were imbedded into growth-factor-reduced Matrigel (BD) and cultured in mammosphere medium 4 for 1 week before imaging and scoring. To passage the colonies Matrigel was dissolved in Cell Recovery Solution (BD) at 4 • C for 30 min. Colonies were recovered and dissociated for the next round of culture in Matrigel. For immunostaining, colonies were fixed in 4% paraformaldehyde (Sigma) for 30 min and then permeabilized in 0.25% Triton X-100 for 30 min. Antibodies were applied in PBS supplement with 10% western blocking reagent (Roche). Images were taken on an LSM510 confocal microscope (Zeiss) at the VUMC Cell Imaging Shared Resource.
Statistical analysis. The analysis for limiting dilution assays was carried out using a webtool described previously 23 . All other analyses for significance were carried out using the two-tailed Student t-test. 
